Accuracy of diagnosis of cancer among autopsy cases: JNIH--ABCC population for Hiroshima and Nagasaki.
Accuracy of diagnosis of cancer among autopsy cases: JNIH--ABCC population for Hiroshima and Nagasaki.
复制标题
尸检病例中癌症诊断的准确性：JNIH--广岛和长崎的 ABCC 人群。
DOI：
10.20772/cancersci1959.67.5_625
复制
发表时间：
1976
期刊：
影响因子：
--
通讯作者：
Hayato Sanefuji
中科院分区：
文献类型：
--
作者：
Arthur Steer;Charles E. Land;Iwao M. Moriyama;Tsutomu Yamamoto;M. Asano;Hayato Sanefuji
在1961年和1970年前后，通过与尸检结果进行比较，确定了广岛和长崎约10万固定人口样本中癌症死亡证明诊断的准确性。一般来说，当死亡证明将癌症列为死亡原因时，在尸检时发现癌症的比例很高。然而，死亡证明上并不总是报告癌症，这表明癌症发生的频率比官方死亡率统计数字所记录的要高。老年人、在家中去世的人和患有某些癌症的人更有可能在死亡证明上没有列出癌症。据估计，在家中或医院发生的10,749例死亡中，死于癌症的人数比死亡证明上证实的人数多32%（3,095人对2,345人），而在70岁或以上的家中死亡的人数中，估计胃癌人数比死亡证明上证实的人数多55%（估计269人对列出的174人），肺癌人数多244%（估计141人对列出的41人）。死亡证明不是子宫颈癌的良好信息来源，因为许多这种疾病的病例在死亡证明上报告为子宫癌。在使用日本宫颈癌死亡率数据时，需要考虑到这种做法。
The accuracy of death certificate diagnoses of cancer in the fixed population of about 100,000 samples in Hiroshima and Nagasaki was determined for the period 1961 approximately 1970 by comparison with autopsy findings. In general, when the death certificate listed cancer as a cause of death it was found at autopsy in a high proportion of cases. However, cancer was not always reported on death certificates, indicating that cancer occurs more frequently than recorded by official mortality statistics. Older persons, persons who die at home, and persons with certain cancers are more likely not to have cancer named on their death certificates. It is estimated that in the 10,749 deaths occurring at home or in hospital, there were 32% more deaths due to cancer than certified on death certificates (3,095 vs. 2,345) and for persons aged 70 or more dying at home it is estimated there were 55% more stomach cancer (269 estimated vs. 174 listed) and 244% more lung cancer (141 estimated vs. 41 listed) than were certified on death certificates. The death certificate is not a good source of information for cancer of the cervix because many cases of this disease reported on death certificates as cancer of the uterus. This practice needs to be taken into account in the use of mortality data for cervical cancer in Japan.